Temporal lobe epilepsy is associated with distinct cognitive phenotypes.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 03 2019
revised: 09 04 2019
accepted: 10 04 2019
pubmed: 12 5 2019
medline: 1 7 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

Neuropsychological assessment is critical for understanding the impact of seizures on cognition and informing treatment decisions. While focus is often placed on examining groups based on seizure type/epilepsy syndrome, an alternate approach emphasizes empirically derived groups based solely on cognitive performance. This approach has been used to identify cognitive phenotypes in temporal lobe epilepsy (TLE). The current study sought to replicate prior work by Hermann and colleagues (2007) and identify cognitive phenotypes in a separate, larger cohort of 185 patients with TLE (92 left TLE, 93 right TLE). Cluster analysis revealed 3- and 4-cluster solutions, with clusters differentiated primarily by overall level of performance in the 3-cluster solution (Low, Middle, and High performance) and by more varying cognitive phenotypes in the 4-cluster solution (Globally Low, Low Executive Functioning/Speed, Low Language/Memory, and Globally High). Differences in cognitive performance as well as demographic and clinical seizure variables are presented. A greater proportion of the patients with left TLE were captured by Cluster 3 (Low Language/Memory) than by the other 3 clusters, though this cluster captured only approximately one-third of the overall group with left TLE. Consistent with prior findings, executive functioning and speed emerged as additional domains of interest in this sample of patients with TLE. The current results extend prior work examining cognitive phenotypes in TLE and highlight the importance of identifying the comprehensive range of potential cognitive profiles in TLE.

Identifiants

pubmed: 31077942
pii: S1525-5050(19)30245-8
doi: 10.1016/j.yebeh.2019.04.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-68

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Kathleen H Elverman (KH)

Medical College of Wisconsin, Department of Neurology, United States of America.

Zachary J Resch (ZJ)

Rosalind Franklin University of Medicine and Science, United States of America.

Erin E Quasney (EE)

Medical College of Wisconsin, Department of Neurology, United States of America.

David S Sabsevitz (DS)

Medical College of Wisconsin, Department of Neurology, United States of America.

Jeffrey R Binder (JR)

Medical College of Wisconsin, Department of Neurology, United States of America.

Sara J Swanson (SJ)

Medical College of Wisconsin, Department of Neurology, United States of America. Electronic address: SSwanson@mcw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH